- Home
- SPFI vs BBOT Comparison
SPFI vs BBOT Comparison
Compare SPFI & BBOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SPFI | BBOT |
|---|---|---|
| Founded | 1941 | 2016 |
| Country | United States | United States |
| Employees | N/A | 106 |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 725.9M | 705.7M |
| IPO Year | 2019 | N/A |
Fundamental Metrics
Financial Performance| Metric | SPFI | BBOT |
|---|---|---|
| Price | $40.47 | $8.55 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 7 |
| Target Price | ★ $46.00 | $24.00 |
| AVG Volume (30 Days) | 87.7K | ★ 362.8K |
| Earning Date | 04-28-2026 | 05-26-2026 |
| Dividend Yield | ★ 1.68% | N/A |
| EPS Growth | ★ 17.81 | N/A |
| EPS | ★ 0.85 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $22.65 | N/A |
| Revenue Next Year | $9.40 | N/A |
| P/E Ratio | $47.34 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $33.66 | $7.60 |
| 52 Week High | $45.09 | $14.87 |
Technical Indicators
Market Signals| Indicator | SPFI | BBOT |
|---|---|---|
| Relative Strength Index (RSI) | 46.77 | 49.24 |
| Support Level | $38.19 | $8.08 |
| Resistance Level | $41.97 | $9.73 |
| Average True Range (ATR) | 0.86 | 0.57 |
| MACD | 0.07 | 0.11 |
| Stochastic Oscillator | 62.58 | 59.04 |
Price Performance
Historical ComparisonAbout SPFI South Plains Financial Inc.
South Plains Financial Inc operates as a bank holding company. The company provides a wide range of commercial and consumer financial services to small and medium-sized businesses and individuals. The principal business activities include commercial and retail banking, along with insurance, investment, trust, and mortgage services. The company has one reportable segment: banking. The majority of the company's revenues is derived from interest income and other sources, including loans, securities and derivatives.
About BBOT BridgeBio Oncology Therapeutics Inc.
BridgeBio Oncology Therapeutics Inc, is a clinical-stage biotechnology company that aims to transform the lives of patients with cancers driven by RAS and PI3Ka, the two frequently mutated oncogenes. The Company operates in one operating and reportable segment within the United States, developing oncology therapies through various related development projects.